Detalles de la búsqueda
1.
Altering lamina assembly reveals lamina-dependent and -independent functions for A-type lamins.
J Cell Sci
; 128(19): 3607-20, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275827
2.
Human caspases in vitro: expression, purification and kinetic characterization.
Protein Expr Purif
; 84(2): 236-46, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22683476
3.
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial.
Lung Cancer
; 169: 77-83, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35660972
4.
Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.
Lung Cancer
; 172: 94-99, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36030612
5.
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials.
Lung Cancer
; 161: 76-85, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543941
6.
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14).
J Thorac Oncol
; 16(2): 278-288, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188912
7.
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial.
J Thorac Oncol
; 15(3): 416-425, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31812754
8.
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial.
J Thorac Oncol
; 15(10): 1647-1656, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32565388
9.
Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism.
Structure
; 15(5): 625-36, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17502107
10.
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP).
J Thorac Oncol
; 14(6): 1086-1094, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30825613
11.
Design, construction, and characterization of a second-generation DARP in library with reduced hydrophobicity.
Protein Sci
; 22(9): 1239-57, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23868333
12.
Selective and sensitive monitoring of caspase-1 activity by a novel bioluminescent activity-based probe.
Chem Biol
; 17(9): 999-1007, 2010 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20851349
13.
The crystal structure of human pyrin b30.2 domain: implications for mutations associated with familial Mediterranean fever.
J Mol Biol
; 394(2): 226-36, 2009 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-19729025
Resultados
1 -
13
de 13
1
Próxima >
>>